Viewing Study NCT00473005


Ignite Creation Date: 2025-12-25 @ 3:09 AM
Ignite Modification Date: 2026-01-08 @ 7:24 AM
Study NCT ID: NCT00473005
Status: TERMINATED
Last Update Posted: 2012-05-28
First Post: 2007-05-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast
Sponsor: Stanford University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module